24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Chengdu Kanghong Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:16
Full list of Israeli high-tech layoffs in 2026
14:13
LinkedIn to shut down Israeli development center and lay off nearly all employees
14:04
China’s AI weather models are challenging the old forecasting order
13:26
OpenAI lets employees cash out $7 billion as IPO plans remain uncertain
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling
2
Israel set to reject $4.2 billion Zim sale despite buyers’ concessions
3
Corma raises $60 million Seed to build AI designed to fight AI-powered cyberattacks
4
Talkspace co-founder Oren Frank dies at 60 after battle with cancer
5
Israel’s Iron Beam laser was hailed as a breakthrough. It still isn’t operational
More news
Chengdu Kanghong Pharma
2 stories about Chengdu Kanghong Pharma
Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company
27.09.18
|
Lilach Baumer
The company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery
Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima
21.11.17
|
Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange
